According to the Centers for Disease Control and Prevention, 1 in 7 adults in the United States will experience a substance use disorder during their lifetime. University of Oklahoma College of ...

The company, launched with help from ex-Novartis executives, is targeting glutamate signaling in the brain to help treat ...

Tempero Bio was created in 2020 by the venture firm Aditum Bio to advance the clinical development of a portfolio of potent, ...

Alcohol use disorder (AUD) is a major global public health issue, affecting more than 28 million adults in the United States ...

There is a connection between alcohol and anxiety the day after you drink for many reasons, even if you’ve not been diagnosed ...

Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

Alcohol contributes to more than 200 health conditions, fueling a staggering 175,000 deaths each year across the U.S.

Researchers conducted a randomized clinical trial examining the effects of semaglutide in non-treatment-seeking adults with alcohol-use disorder.

Teens who have parental permission to drink are more likely to develop unhealthy relationships with alcohol as adults, a ...

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...